3011.75 CH, 1.5 Rx Regenerative Medicine: Innovations to Treat Kidney Disease

Thomas Gonwa, MD, FACP, FASN

The future is here... the future is now. Yes, there is possibly a future for the CKD patient that may not include dialysis. What does current research indicate? Are there patients for whom stem cells may hold a different outcome than replacement therapy? Dr. Gonwa, a researcher in regenerative medicine focusing on renal disease, will share a glimpse of what current research holds for patient care.

3112.0 CH Mastering Precepting

Beth Ulrich, EdD, RN, FACHE, FAAN

Precepting is an organized, evidence-based, outcome-driven approach to ensure competent care. Preceptors are the essential link between what nurses are taught and what they do and between what nurses know and what they need to know. Preceptors live at the intersections of education and practice and of the present and the future. They are where theoretical learning meets reality. Myths, the role of a preceptor, and strategies and techniques will be the focus of this important session.

3122.0 CH An International Perspective on Chronic Kidney Disease

Lesley Dinwiddie, MSN, RN, FNP, CNN

How do other countries care for patients with CKD? Are there differences in the delivery and philosophy of patient care in other countries? Do health care providers face similar issues and challenges? What is unique to the care issues faced abroad? As the Affordable Care Act is implemented, can we learn from the CKD care provided in other countries? Listen to an individual who has practiced in both the U.S. and abroad and hear the interesting details that unfurl.

3132.0 CH, 1.0 Rx Sepsis: The Untold Story

Delores Schultz, BSN, RN, CCRN

Great strides have been made at decreasing the rates of blood infections through central lines in the hospital setting. That has not been the case with dialysis units or dialysis patients. The pathophysiology of the disease process and the potential sequelae of events that occur are often overlooked in the care of the CKD patient. The impact of sepsis on quality measures, patient outcomes, and the bottom line will be analyzed. Current best practices also will be discussed.

3142.0 CH, 1.0 Rx Viral Infections in Kidney Transplantation

Dave Wojciechowski, DO

Viruses can cause an alarming issue for the immunocompromised patient. This session will review the most common viruses affecting the individual with a kidney transplant, review the presentation of clinical symptomatology, and analyze when these infections are most likely to present. In a case study format, key elements of patient care will be identified and discussed.